Skip to main content
Signal8

Green Charles Bruce

SEC insider (Form 3/4/5 filer). CIK 0001945398. Director at Humacyte, Inc. (HUMA). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in DURHAM, NC.

Companies Green Charles Bruce has filed insider reports for

  • Humacyte, Inc. (HUMA): Director
Green Charles Bruce profile photo

Green Charles Bruce

CIK: 0001945398

Transaction Breakdown

Open Market Buys (P)1 (25.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (25.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Humacyte, Inc. logo
HUMA

Humacyte, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Jun 11, 2026
    Award

    Stock Options (right to buy)

    Direct
    80K shares-
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Jun 12, 2025
    Award

    Stock Options (right to buy)

    Direct
    80K shares-
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Apr 8, 2025
    Purchase
    Direct
    6K shares at avg. $1.29$8K
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Sep 13, 2024
    Exercise
    Direct
    1.2K shares at avg. $4.09$5K

1-4 of 4